I. Jensen

Carbohydrate and Lipid Metabolism of Skeletal Muscle in Type 2 Diabetic Patients

K. Falholt, I. Jensen, S L Jensen et al. · Diabetic Medicine · 1988 · 124 citations

Cost-effectiveness analysis of using onasemnogene abeparvocec (AVXS-101) in spinal muscular atrophy type 1 patients

Daniel C. Malone, Rebecca Dean, R. Arjunji et al. · Journal of Market Access & Health Policy · 2019 · 92 citations · Full text

In Vitro and In Vivo Potency of Insulin Analogues Designed for Clinical Use

Aa. Vølund, Jens Brange, Kirsten Drejer et al. · Diabetic Medicine · 1991 · 75 citations

An updated cost-utility model for onasemnogene abeparvovec (Zolgensma®) in spinal muscular atrophy type 1 patients and comparison with evaluation by the Institute for Clinical and Effectiveness Review (ICER)

Rebecca Dean, I. Jensen, Phil Cyr et al. · Journal of Market Access & Health Policy · 2021 · 46 citations · Full text

Action profiles of fast onset insulin analogues

Lutz Heinemann, A. Starke, Lise G. Hedïng et al. · Diabetologia · 1990 · 37 citations · Full text

Action Profiles, Medicine, Diabetes +7